Exact Sciences Corporation (EXAS)

USD 57.38

(-4.95%)

EBITDA Summary of Exact Sciences Corporation

  • Exact Sciences Corporation's latest annual EBITDA in 2023 was 41.87 Million USD , up 97.26% from previous year.
  • Exact Sciences Corporation's latest quarterly EBITDA in 2024 Q3 was 3.1 Million USD , down -24.62% from previous quarter.
  • Exact Sciences Corporation reported an annual EBITDA of -386.73 Million USD in 2022, up 35.16% from previous year.
  • Exact Sciences Corporation reported an annual EBITDA of -617.72 Million USD in 2021, down -59.26% from previous year.
  • Exact Sciences Corporation reported a quarterly EBITDA of 31.09 Million USD for 2024 Q2, up 174.92% from previous quarter.
  • Exact Sciences Corporation reported a quarterly EBITDA of 3.1 Million USD for 2024 Q3, down -24.62% from previous quarter.

Annual EBITDA Chart of Exact Sciences Corporation (2023 - 1998)

Historical Annual EBITDA of Exact Sciences Corporation (2023 - 1998)

Year EBITDA EBITDA Growth
2023 41.87 Million USD 97.26%
2022 -386.73 Million USD 35.16%
2021 -617.72 Million USD -59.26%
2020 -632.85 Million USD -113.53%
2019 -217.74 Million USD -36.54%
2018 -115.18 Million USD -34.79%
2017 -98.82 Million USD 30.0%
2016 -155.48 Million USD -6.25%
2015 -150.04 Million USD -58.22%
2014 -96.28 Million USD -116.47%
2013 -45.02 Million USD 11.33%
2012 -51.39 Million USD -84.36%
2011 -28.25 Million USD -139.97%
2010 -11.32 Million USD -28.5%
2009 -9.07 Million USD -13.15%
2008 -8.74 Million USD 22.4%
2007 -12.84 Million USD 18.18%
2006 -14.16 Million USD 10.83%
2005 -15.63 Million USD 25.07%
2004 -19.19 Million USD 33.44%
2003 -28.83 Million USD -0.53%
2002 -28.68 Million USD -14.37%
2001 -25.13 Million USD -282.49%
2000 -9.74 Million USD -35.52%
1999 -4.83 Million USD -20.33%
1998 -4.02 Million USD 0.0%

Peer EBITDA Comparison of Exact Sciences Corporation

Name EBITDA EBITDA Difference
Bionano Genomics, Inc. -213.6 Million USD 119.605%
Prenetics Global Limited -47.89 Million USD 187.431%
Star Equity Holdings, Inc. -1.68 Million USD 2582.276%
CareDx, Inc -89.65 Million USD 146.707%
Exagen Inc. -19.15 Million USD 318.639%
Inotiv, Inc. -26.5 Million USD 257.987%
Guardant Health, Inc. -433.3 Million USD 109.664%
Biodesix, Inc. -37.1 Million USD 212.864%
BioNexus Gene Lab Corp. -2.48 Million USD 1785.042%
Precipio, Inc. -4.31 Million USD 1069.801%
iSpecimen Inc. -9.1 Million USD 559.988%
Natera, Inc. -383.27 Million USD 110.926%
Aspira Women's Health Inc. -16.49 Million USD 353.932%
Standard BioTools Inc. -54.45 Million USD 176.897%
23andMe Holding Co. -291.87 Million USD 114.347%
Castle Biosciences, Inc. -45.02 Million USD 193.008%
Personalis, Inc. -96.8 Million USD 143.257%
Aclaris Therapeutics, Inc. -117.56 Million USD 135.619%
Applied DNA Sciences, Inc. -9.59 Million USD 536.616%
OpGen, Inc. -29.51 Million USD 241.9%
T2 Biosystems, Inc. -43.87 Million USD 195.444%
Myriad Genetics, Inc. -67.8 Million USD 161.764%
ICON Public Limited Company 1.63 Billion USD 97.434%
NeoGenomics, Inc. -17.6 Million USD 337.837%
Star Equity Holdings, Inc. -1.68 Million USD 2582.276%
IDEXX Laboratories, Inc. 1.21 Billion USD 96.561%
RadNet, Inc. 292.78 Million USD 85.697%
MDxHealth SA -30.46 Million USD 237.443%
Psychemedics Corporation -251 Thousand USD 16783.665%
Illumina, Inc. -608 Million USD 106.888%
Check-Cap Ltd. -17.64 Million USD 337.271%
Twist Bioscience Corporation -176.7 Million USD 123.698%
DarioHealth Corp. -53.49 Million USD 178.282%
Fulgent Genetics, Inc. -46.55 Million USD 189.955%
Sera Prognostics, Inc. -35.28 Million USD 218.673%
ENDRA Life Sciences Inc. -9.78 Million USD 527.97%
OPKO Health, Inc. -65.51 Million USD 163.917%
Medpace Holdings, Inc. 363.15 Million USD 88.469%
Neogen Corporation 182.59 Million USD 77.066%
Intelligent Bio Solutions Inc. -8.81 Million USD 575.285%
Prenetics Global Limited -47.89 Million USD 187.431%
Mainz Biomed B.V. -25.01 Million USD 267.429%
bioAffinity Technologies, Inc. -7.62 Million USD 648.884%
Trinity Biotech plc -24.09 Million USD 273.774%
Neuronetics, Inc. -22.75 Million USD 283.998%
Sotera Health Company 514.14 Million USD 91.855%
bioAffinity Technologies, Inc. -7.62 Million USD 648.884%